ClinicalTrials.gg
RecruitingNCT07618208PEPSYUpdated Nov 6, 2026

Student Precarity and Psychiatry

An observational study in Depressive Disorder, Major, Generalized Anxiety Disorder and Suicidal Ideation, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Assistance Publique - Hôpitaux de Paris · Observational

How we know

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 6, 2026Now RecruitingFirst site in France+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
45,000
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 127 studies in Depressive Disorder, Major with a site in France — 28 open to participants now, 31 under way, 2 of them phase 3. Depressive Disorder, Major · France.

Planned enrollment
Largest of 21
45,000 · median 128
Started
2026
with 6 others
Observational
21 of 127
7 open now
Primary completion
2028-10
later than 25 of 30 live
Registered
124th of 127
by date
Lead sponsor
7 of 127
Assistance Publique - Hôpitaux de Paris

Among the 127 studies in Depressive Disorder, Major with a site in France, this one has the largest planned enrollment of the 21 observational ones that give a count, is one of 7 that started in 2026, is one of 21 observational ones, reaches primary completion later than 25 of the 30 other live ones, and was the 124th registered.

Depressive Disorder, Major

3,051 studies on the registry are indexed under Depressive Disorder, Major; 596 are open to participants now.

Browse Depressive Disorder, Major studies →

Open to participants now

28 of the 127 studies in Depressive Disorder, Major with a site in France are open now. Recruiting first, the newest first:

22 more — sign in →

All 28 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 419 Depressive Disorder, Major studies recruiting now, 93 (22%) set no upper age limit and 299 (71%) stop at 75 or younger; 55 take children under 18; 100 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 127 studies in Depressive Disorder, Major with a site in France, or all of them as a file.
02

Study summary

Since the COVID-19 pandemic, mental health disorders have increased significantly, particularly among young people. In France, the proportion of young people aged 18 to 25 suffering from depression almost doubled between 2017 and 2021. This phenomenon particularly affects students, who are already identified as being at greater risk of mental health disorders than the general population. Medical students seem to be particularly vulnerable: in 2021, a national study showed very high rates of depression and suicidal thoughts in this population. The main factor associated with depression was the feeling of financial hardship.

Students often face multiple forms of insecurity. Financially, they have limited resources and struggle to cover their basic needs such as housing, food and healthcare. Socially, many experience significant isolation, particularly when they are away from their families or under pressure from their studies. All of this has a significant impact on their mental health. Unfortunately, many students do not seek help due to lack of time, resources, or awareness of support services. The 2021 study showed that only one-third of medical students suffering from depression received appropriate treatment.

The aim of our study is to assess the impact of precariousness on the onset of psychiatric disorders and on the use or non-use of healthcare services.

Our study will involve nearly 45,000 students from PSL and UPC universities. It is based on a longitudinal cohort (via questionnaires) over three years. The aim is to identify precisely the different aspects of student precariousness (housing, transport, isolation, economic difficulties, etc.) and their link with psychological distress. The study will measure the extent of the phenomenon and identify modifiable factors that could be targeted by preventive measures. The results will enable us to better target preventive measures and propose concrete solutions to improve students' well-being and promote their success.

Read the detailed description

The COVID-19 pandemic has led to an increase in depression, particularly among young people. The French health barometer, conducted every 4-5 years by Santé Publique France (SPF), found that the prevalence of major depressive episodes (MDE) among 18-25 year olds doubled (from 11.7% to 20.8%) between 2017 and 2021. There has also been an increase in suicidal thoughts and suicide attempts. Among students, data from the 2016 Student Life Observatory (OVE) found a higher prevalence of CDE and suicidal thoughts among students than in the general population of the same age. Among the factors associated with the risk of EDC, experiencing significant financial difficulties was the main one[4]. Among medical students, a national study conducted in 2021 found that the prevalence of depression and suicidal thoughts was much higher than in the general population of the same age. Financial difficulties were also the main factor associated with the risk of depression. Indeed, students are a population that is particularly vulnerable to precariousness due to several factors. Economically, they often have limited incomes, depending on parental support, insufficient grants or precarious jobs. This exposes them to difficulties in meeting their basic needs such as housing, food and healthcare. Socially, isolation can exacerbate their situation, especially when they are far from their family network or under pressure from their studies. In addition, high academic demands, combined with unstable living conditions, impact their mental health and can contribute to the development of psychiatric disorders, which often go untreated due to a lack of affordable and accessible resources. International students are even more vulnerable due to language and administrative barriers and limited access to local support services. This multidimensional precariousness highlights the need for comprehensive support for this population, even though students are unlikely to seek professional help. In the 2021 survey, only 32% of medical students suffering from depression received adequate care. If we want to improve the health of medical students, we must not only treat disorders, but also prevent them from occurring by helping students strive for a state of well-being. In terms of prevention, the Haute Autorité de Santé (HAS) distinguishes between three levels: primary prevention, which acts upstream of the disease (on risk factors); secondary prevention, which acts at an early stage of its development (screening); and tertiary prevention, which acts on complications and the risk of recurrence.

The objectives of the study are to identify and quantify the modifiable predictive and moderating factors explaining students' psychological distress that could give rise to (primary) prevention actions by studying the various components of precariousness (housing, transport, study conditions, social isolation, grants, etc.). It also aims to study the impact of the various components of precariousness on the use and non-use of healthcare (screening and treatment, secondary and tertiary prevention).

The data will be entered directly by participants on the SKEZIA platform (https://skezi.eu/) (a solution developed by SKEZI) co-founded by AP-HP and Paris-Cité University, and will be hosted on HDS-approved servers.

Main objective:

The objective is to explore the impact of precariousness on the risk of characterised depressive episodes and the use of healthcare among PSL students (17,000 students) and UPC health faculty students (28,000 students).

Primary outcome measure:

The study will assess the 12-month prevalence of:

  • characterised depressive episodes (using the Composite International Diagnostic Interview Short-Form (CIDI-SF)) and suicidal ideation in the same way as SPF and OVE;
  • use of healthcare services, which will be measured in a similar way to the OVE survey and the medical student survey.

Precariousness will be assessed by the question: 'Would you say that you are currently experiencing financial difficulties?'

Secondary objectives and evaluation criteria:

The secondary objectives are to :

  • evaluate the prevalence of :
  • anxiety, which will be assessed using the GAD7;
  • eating disorders, which will be assessed using the SCOFF;
  • alcohol addiction, which will be assessed using the AUDIT, and cannabis addiction, which will be assessed using the CAST;
  • burnout, using the student version, which will be assessed using the MBI-SS for pre-clinical or healthcare students and the MBI-HSS for externs and residents,
  • dropout, which will be assessed by a single question as in the CNA-CORE survey,
  • insomnia, which will be measured by the Insomnia Severity Index (ISI),
  • loneliness, which will be assessed using the UCLA 3 items,
  • harassment,
  • discriminatory treatment,
  • and quality of life (WHOQOL);
  • identify and quantify modifiable predictive and moderating factors explaining students' psychological distress that could lead to (primary) prevention measures = by studying the various components of precariousness (housing, transport, study conditions, social isolation, grants, etc.),
  • study the impact of the various components of precariousness on the use and non-use of healthcare (screening and treatment, secondary and tertiary prevention). This will be assessed using questions on the renunciation of healthcare and its causes.
03

Conditions studied

  • Depressive Disorder, Major
  • Generalized Anxiety Disorder
  • Suicidal Ideation
  • Loneliness

Keywords

  • Students
  • Depression
  • Use of care
  • Precarity
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All students enrolled at Paris Sciences et Lettres University or the Faculty of Health Sciences at Paris Cité University.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Student enrolled at Paris Sciences et Lettres University (PSL, 17,000 students) or the Faculty of Health Sciences at Paris Cité University (UPC, 28,000 students),
  • Aged 18 or over,
  • Fluent in French,
  • Affiliated to a health insurance.

Exclusion criteria

Exclusion Criteria:

  • Applicants under the age of 18,
  • Not enrolled at PSL universities or the UPCS Faculty of Health,
  • Insufficient level of French.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
45,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Health students

    All students enrolled at the Faculty of Health Sciences of Paris Cité University

    Other: Questionnaires

  • Non-health students

    All students enrolled at Paris Sciences and Letters University

    Other: Questionnaires

Interventions

  • OtherQuestionnaires

    Questionnaires

06

What researchers measure

Primary outcomes

  1. Composite International Diagnostic Interview Short-Form (CIDI-SF)

    12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)

    Time frame: Day 0

  2. Composite International Diagnostic Interview Short-Form (CIDI-SF)

    12-months prevalence Major Depressive Disorder and suicidal thoughts Composite International Diagnostic Interview Short-Form (CIDI-SF)

    Time frame: 12 months

  3. Use of care

    Use of care service of care professional

    Time frame: Day 0

  4. Use of care

    Use of care service of care professional

    Time frame: 12 months

  5. Precarity

    Question "Would you say that you are currently experiencing financial difficulties?"

    Time frame: Day 0

  6. Precarity

    Question "Would you say that you are currently experiencing financial difficulties?"

    Time frame: 12 months

Secondary outcomes

  1. GAD7

    Prevalence of anxiety

    Time frame: Day 0

  2. GAD7

    Prevalence of anxiety

    Time frame: 12 months

  3. GAD7

    Prevalence of anxiety

    Time frame: 24 months

  4. SCOFF

    Prevalence of Eating disorders

    Time frame: Day 0

  5. SCOFF

    Prevalence of Eating disorders

    Time frame: 12 months

  6. SCOFF

    Prevalence of Eating disorders

    Time frame: 24 months

  7. AUDIT

    Prevalence of Alcohol addiction

    Time frame: Day 0

  8. AUDIT

    Prevalence of Alcohol addiction

    Time frame: 12 months

  9. AUDIT

    Prevalence of Alcohol addiction

    Time frame: 24 months

  10. CAST

    Prevalence of cannabis addiction

    Time frame: Day 0

  11. CAST

    Prevalence of cannabis addiction

    Time frame: 12 months

  12. CAST

    Prevalence of cannabis addiction

    Time frame: 24 months

  13. MBI-SS or MBI-HSS

    Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents

    Time frame: Day 0

  14. MBI-SS or MBI-HSS

    Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents Time Frame: D0

    Time frame: 12 months

  15. MBI-SS or MBI-HSS

    Prevalence of Burnout using the student version : will be assessed using the MBI-SS for pre-clinical students or caregivers or Prevalence of Burnout using the student version : will be assessed using the MBI-HSS for externs and residents Time Frame: D0

    Time frame: 24 months

  16. A single question as in the CNA-CORE survey

    Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey

    Time frame: Day 0

  17. A single question as in the CNA-CORE survey

    Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey

    Time frame: 12 months

  18. A single question as in the CNA-CORE survey

    Prevalence of Dropout: will be assessed using a single question as in the CNA-CORE survey

    Time frame: 24 months

  19. Insomnia Severity Index (ISI)

    Prevalence of Insomnia

    Time frame: Day 0

  20. Insomnia Severity Index (ISI)

    Prevalence of Insomnia

    Time frame: 12 months

  21. Insomnia Severity Index (ISI)

    Prevalence of Insomnia

    Time frame: 24 months

  22. UCLA 3 items

    Prevalence of Loneliness

    Time frame: Day 0

  23. UCLA 3 items

    Prevalence of Loneliness

    Time frame: 12 months

  24. UCLA 3 items

    Prevalence of Loneliness

    Time frame: 24 months

  25. Questions about harrassment

    Harrassment

    Time frame: Day 0

  26. Questions about harrassment

    Harrassment

    Time frame: 12 months

  27. Questions about harrassment

    Harrassment

    Time frame: 24 months

  28. Questions about discriminatory treatment

    Discriminatory treatment

    Time frame: Day 0

  29. Questions about discriminatory treatment

    Discriminatory treatment

    Time frame: 12 months

  30. Questions about discriminatory treatment

    Discriminatory treatment

    Time frame: 24 months

  31. WHOQOL

    Quality of life

    Time frame: Day 0

  32. WHOQOL

    Quality of life

    Time frame: 12 months

  33. WHOQOL

    Quality of life

    Time frame: 24 months

  34. Components of precariousness

    Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).

    Time frame: Day 0

  35. Components of precariousness

    Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).

    Time frame: 12 months

  36. Questions on the renunciation of healthcare and its causes.

    Impact of the various components of precariousness on the use and non-use of healthcare will be assessed using questions on the renunciation of healthcare and its causes.

    Time frame: 12 months

  37. Components of precariousness

    Predictive and moderating factors = by studying the different components of precariousness (housing, transport, study conditions, social isolation, grants, etc.).

    Time frame: 24 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Oct 2028, 24 months after the start.

Of 121 non-industry observational studies under Depressive Disorder, Major, half reached primary completion within 46 months of starting (the median), counting those still running; a quarter within 29 and three quarters within 73. This study's planned 24 months is below that.

Counting every sponsor, half of 150 studies reached it within 38 months; a quarter within 21 and three quarters within 67.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: start Sep 2026 → Oct 2026, primary completion Sep 2028 → Oct 2028 and completion Nov 2028 → Dec 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 4, 2026
First posted
Jun 1, 2026
StartActual
Oct 19, 2026was Sep 2026
Primary completionEst.
Oct 2028was Sep 2028
CompletionEst.
Dec 2028was Nov 2028
Last update
Nov 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 6, 2026
Sites
1 site added — first site in France
Show site
  • Hôtel-Dieu hospital - APHP · Paris, France
Nov 6, 2026
Start date
Sep 2026→Oct 19, 2026 (actual)
Nov 6, 2026
Primary completion
Sep 2028→Oct 2028
Nov 6, 2026
Study completion
Nov 2028→Dec 2028
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Not yet recruiting→Recruiting
    1 site added — first site in France
    Show site
    • Hôtel-Dieu hospital - APHP · Paris, France
    Start date Sep 2026→Oct 19, 2026 (now actual)
    Primary completion Sep 2028→Oct 2028
    Study completion Nov 2028→Dec 2028
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07618208
Collaborators
Institut de Psychiatrie et Neurosciences de Paris (INSERM), URC-CIC Paris Descartes Necker Cochin
Responsible party
Sponsor
First posted
Jun 1, 2026
Start date
Oct 19, 2026
Primary completion
Oct 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Nov 6, 2026

Study contacts

Cédric LEMOGNE, PR
Contact
cedric.lemogne@aphp.fr
00331 42 34 85 76
Marie Benhammani-Godard
Contact
marie.godard@aphp.fr
0033158411190

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion